Co-Authors
This is a "connection" page, showing publications co-authored by Jeff Slezak and Hung Tseng.
Connection Strength
1.205
-
Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection. J Infect Dis. 2020 09 14; 222(8):1298-1310.
Score: 0.186
-
Cost of Hospitalization Associated With Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults. J Infect Dis. 2020 08 17; 222(6):962-966.
Score: 0.185
-
Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old. Vaccine. 2020 01 10; 38(2):228-234.
Score: 0.175
-
Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years. Pediatr Infect Dis J. 2017 Nov; 36(11):1087-1092.
Score: 0.153
-
Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds. Pediatrics. 2017 01; 139(1).
Score: 0.144
-
Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study. Vaccine. 2012 Aug 17; 30(38):5625-30.
Score: 0.106
-
Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA. 2010 May 05; 303(17):1699-706.
Score: 0.091
-
Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System. JAMA Netw Open. 2023 Jan 03; 6(1):e2251833.
Score: 0.055
-
Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults. Clin Infect Dis. 2018 Nov 19.
Score: 0.041
-
Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization. Vaccine. 2017 02 07; 35(6):897-902.
Score: 0.036
-
Quadrivalent Human Papillomavirus Vaccine Initiation in Boys Before and Since Routine Use: Southern California, 2009-2013. Am J Public Health. 2015 Dec; 105(12):2549-56.
Score: 0.033